Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Aberdeen’s £40 million One BioHub opens Monday

Leading businesswoman hails it as 'beacon of ambition for the future'.

Opportunity North East (One) chief executive Jennifer Craw and One life sciences chairwoman Deborah O'Neil in the new building.
l-r Opportunity North East (One) CEO Jennifer Craw and One life sciences chairwoman Deborah O'Neil. Image: Wullie Marr / DC Thomson

Aberdeen’s reputation as an important centre for drug research and development (R&D) will take another major leap forward when the £40 million BioHub opens next week.

The Granite City is already home to a raft of companies doing exciting work on treatments and potential cures for a wide range of illnesses and other health problems.

One BioHub, on the hospital campus at Foresterhill, is expected to take life sciences in the north-east to another level.

It will provide support and infrastructure to help grow businesses, nurture commercialisation opportunities, and connect academics and health researchers to industry.

‘Milestone marker’

Jennifer Craw is chief executive of one of the funding partners behind it, Opportunity North East (One).

She told The Press and Journal the new building is a “milestone marker” for investment in the region’s economy.

Local economic priorities have changed since One launched in late 2015.

Ms Craw added: “The one thread that’s continued is diversification of the regional economy, so strengthening new, high-value jobs.”

Jennifer Craw, chief executive of Opportunity North East (One).
Jennifer Craw. Image: Wullie Marr / DC Thomson

The region’s life sciences sector is a key part of this, with a “rich stream” of research and innovation as well as university expertise helping to build future economic prosperity, she said.

She hailed the new 69,000sq ft BioHub, which has its official opening on Monday, as a “major milestone”.

One’s CEO continued: “The investment has created a physical presence, a beacon of ambition for the future.

“This is the kind of stamp, an embodiment of that ambition to to grow “north-east life sciences) to the next phase and stage.”

Exterior of BioHub building in Aberdeen.
BioHub in Aberdeen. Image: Wullie Marr / DC Thomson

One is on a mission to double the number of companies in the region’s life sciences cluster by 2027.

Leading the way is the economic development partnership’s life sciences sector board chairwoman, Deborah O’Neil.

BioHub will make a big difference, attract investors and put north-east firms on a global stage, Ms O’Neil said.

She added: “The sector is already thriving. Individual companies have been recognised globally but not the cluster as a whole.

“The piece that’s always been missing, which brings that all together, is now here. BioHub is a kind of physical centre-point.”

Deborah O'Neil.
Deborah O’Neil. Image: Wullie Marr / DC Thomson

Ms O’Neil, who is also chief executive and scientific officer of Aberdeen biotechnology company Novabiotics, said she expected the sector to “accelerate from this point on”.

She added: “Bio entrepreneurs of the future can actually see a destination.

“They know what the pathway is, beyond the building, through everything that Opportunity North East life sciences is offering for the cluster in terms of networking, training and bringing in resources.”

The economic potential is, of course, important but it goes beyond that.

Bio entrepreneurs of the future can actually see a destination.”

Deborah O’Neil, Opportunity North East/Novabiotics

Ms O’Neill said: “If you look at the areas that we are developing solutions for, either in therapies or medtech, it’s not just pills and injections.

“It’s cancer, it’s inflammation, dementia and microbiome.

“We’re delivering on those kind of massive global health problems.

“But these health problems are absolutely relevant to the local population as well.

‘Fantastic-looking’ building

“It’s important for people to know that, here in this fantastic-looking building, research is going on.

“And not just early-stage, nice research that will generate papers, but by companies who are determined to actually see those products through, and to get to patients and deliver benefits as well as being a commercial success.

‘We’re not just doing science in a bubble’

“This is why the location of this is key, because we’re on the health campus. We’re not just doing science in a bubble.”

Pointing towards the nearby hospital, she said: “There’s some fantastic stuff going on over there.

“This is about the companies that can turn those ideas into solutions that impact your health.”

BioHub sign.
Image: Wullie Marr / DC Thomson

Other BioHub partners include Aberdeen University, NHS Grampian, and the Aberdeen City Region Deal.

The project secured £20m of capital funding from the UK and Scottish governments through the city region deal, a partnership between both governments, Aberdeen City Council, Aberdeenshire Council and One.

One has committed up to £5.6m to deliver its ambitions and Scottish Enterprise is contributing £2m.

Project delays

BioHub was built on a fixed price contract but the construction project, led by Robertson Group, suffered delays due to Covid, supply chain issues and two subcontractors going bust.

Ms Craw added: “They were they were  part of the challenges but, in terms of cost, we came in on budget.”

North-east life sciences firms, including the likes of Novabiotics, Elasmogen, EnteroBiotix and TauRx, employ about 2,500 people.

Conversation